T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$4.95B |
| 2 |
Broadcom
AVGO
|
+$3.48B |
| 3 |
Microsoft
MSFT
|
+$2.66B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.92B |
| 5 |
GE Aerospace
GE
|
+$1.49B |
Top Sells
| 1 |
Amazon
AMZN
|
+$3.79B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$2.63B |
| 3 |
Apple
AAPL
|
+$2.46B |
| 4 |
Fiserv
FI
|
+$2.19B |
| 5 |
Eli Lilly
LLY
|
+$1.78B |
Sector Composition
| 1 | Technology | 34.76% |
| 2 | Financials | 12.08% |
| 3 | Healthcare | 10.97% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Nektar Therapeutics
NKTR
$926M
| $460K | ﹤0.01% |
17,798
+706
| +4% | +$18.2K |
|
2327
Peapack-Gladstone Financial
PGC
$517M
| $459K | ﹤0.01% |
16,221
+538
| +3% | +$15.2K |
|
2328
iShares Biotechnology ETF
IBB
$5.65B
| $458K | ﹤0.01% |
3,614
| – | – |
|
|
GMRE
2329
Global Medical REIT
GMRE
$512M
| $455K | ﹤0.01% |
65,517
+5,079
| +8% | +$35.3K |
|
2330
Monro
MNRO
$519M
| $454K | ﹤0.01% |
30,395
+827
| +3% | +$12.4K |
|
|
NPKI
2331
NPK International Inc.
NPKI
$889M
| $452K | ﹤0.01% |
53,032
+4,819
| +10% | +$41.1K |
|
2332
Methode Electronics
MEI
$287M
| $451K | ﹤0.01% |
47,333
+2,002
| +4% | +$19.1K |
|
2333
Bowman Consulting
BWMN
$703M
| $449K | ﹤0.01% |
15,598
+1,295
| +9% | +$37.3K |
|
2334
SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$11.4B
| $449K | ﹤0.01% |
5,983
| – | – |
|
2335
Pagaya Technologies
PGY
$3.04B
| $448K | ﹤0.01% |
21,000
+4,940
| +31% | +$105K |
|
2336
Stagwell
STGW
$1.35B
| $448K | ﹤0.01% |
99,464
-513,014
| -84% | -$2.31M |
|
2337
LSB Industries
LXU
$576M
| $447K | ﹤0.01% |
57,228
+2,597
| +5% | +$20.3K |
|
|
CMRC
2338
Commerce.com, Inc. Series 1 Common Stock
CMRC
$370M
| $446K | ﹤0.01% |
89,129
+1,416
| +2% | +$7.09K |
|
|
SVC
2339
Service Properties Trust
SVC
$476M
| $445K | ﹤0.01% |
186,033
+5,228
| +3% | +$12.5K |
|
2340
Primis Financial Corp
FRST
$269M
| $444K | ﹤0.01% |
40,909
+8,317
| +26% | +$90.3K |
|
2341
Navitas Semiconductor
NVTS
$1.31B
| $444K | ﹤0.01% |
67,723
+12,791
| +23% | +$83.9K |
|
2342
N-able
NABL
$1.54B
| $443K | ﹤0.01% |
54,671
+2,965
| +6% | +$24K |
|
2343
MBIA
MBI
$393M
| $441K | ﹤0.01% |
101,449
+1,257
| +1% | +$5.46K |
|
2344
Quanex
NX
$661M
| $441K | ﹤0.01% |
23,330
+2,935
| +14% | +$55.5K |
|
2345
Conduent
CNDT
$445M
| $439K | ﹤0.01% |
166,170
+2,408
| +1% | +$6.36K |
|
2346
QuinStreet
QNST
$930M
| $439K | ﹤0.01% |
27,243
+3,854
| +16% | +$62.1K |
|
|
LENZ
2347
LENZ Therapeutics
LENZ
$1.18B
| $438K | ﹤0.01% |
14,933
-292,045
| -95% | -$8.57M |
|
2348
ReposiTrak
TRAK
$311M
| $434K | ﹤0.01% |
22,086
-439
| -2% | -$8.63K |
|
2349
Metals Acquisition
MTAL
$1.01B
| $432K | ﹤0.01% |
35,662
+11,956
| +50% | +$145K |
|
2350
Prothena Corp
PRTA
$442M
| $432K | ﹤0.01% |
71,047
-3,384,809
| -98% | -$20.6M |
|